MedPath

CBP-174

Generic Name
CBP-174

Safety, Tolerability and Pharmacokinetics of CBP-174 in Healthy Adults

Phase 1
Completed
Conditions
Healthy Adult Subjects
Interventions
Drug: Placebo
First Posted Date
2021-03-23
Last Posted Date
2022-08-10
Lead Sponsor
Connect Biopharma Australia Pty Ltd
Target Recruit Count
74
Registration Number
NCT04811469
Locations
🇦🇺

Nucleus Network Pty Ltd, Melbourne, Victoria, Australia

© Copyright 2025. All Rights Reserved by MedPath